 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Human cdc25a catalytic domain
|
|
Structure:
|
 |
Cdc25a. Chain: a. Fragment: catalytic domain. Synonym: m-phase inducer phosphatase 1. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Cellular_location: cytoplasm. Gene: cdc25a. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.227
|
R-free:
|
0.296
|
|
|
Authors:
|
 |
E.B.Fauman,J.P.Cogswell,B.Lovejoy,W.J.Rocque,W.Holmes, V.G.Montana,H.Piwnica-Worms,M.J.Rink,M.A.Saper
|
Key ref:
|
 |
E.B.Fauman
et al.
(1998).
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A.
Cell,
93,
617-625.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Apr-98
|
Release date:
|
19-Aug-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P30304
(MPIP1_HUMAN) -
M-phase inducer phosphatase 1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
524 a.a.
161 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.3.48
- Protein-tyrosine-phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Protein tyrosine phosphate + H2O = protein tyrosine + phosphate
|
 |
 |
 |
 |
 |
Protein tyrosine phosphate
|
+
|
H(2)O
|
=
|
protein tyrosine
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
intracellular
|
1 term
|
 |
|
Biological process
|
M phase of mitotic cell cycle
|
2 terms
|
 |
|
Biochemical function
|
protein tyrosine phosphatase activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Cell
93:617-625
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A.
|
|
E.B.Fauman,
J.P.Cogswell,
B.Lovejoy,
W.J.Rocque,
W.Holmes,
V.G.Montana,
H.Piwnica-Worms,
M.J.Rink,
M.A.Saper.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cdc25 phosphatases activate the cell division kinases throughout the cell cycle.
The 2.3 A structure of the human Cdc25A catalytic domain reveals a small
alpha/beta domain with a fold unlike previously described phosphatase structures
but identical to rhodanese, a sulfur-transfer protein. Only the active-site
loop, containing the Cys-(X)5-Arg motif, shows similarity to the tyrosine
phosphatases. In some crystals, the catalytic Cys-430 forms a disulfide bond
with the invariant Cys-384, suggesting that Cdc25 may be self-inhibited during
oxidative stress. Asp-383, previously proposed to be the general acid, instead
serves a structural role, forming a conserved buried salt-bridge. We propose
that Glu-431 may act as a general acid. Structure-based alignments suggest that
the noncatalytic domain of the MAP kinase phosphatases will share this topology,
as will ACR2, a eukaryotic arsenical resistance protein.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Ribbon Drawing of the Catalytic Domain of Human
Cdc25AThe CH2A, active site, and CH2B motifs are indicated in
green, red, and blue, respectively. The side chain of the
Cys-430 nucleophile is shown in yellow. The N terminus (residue
335) is indicated on the left (N), while the C terminus extends
toward the viewer and is clipped in this figure. Figure created
with MOLSCRIPT ([31]) and the ray-tracing program VORT
(University of Melbourne).
|
 |
Figure 5.
Figure 5. The Active Site of Cdc25A(A) Ball-and-stick
model.(B) CPK model, in the same orientation, with a molecular
surface ([37]) in gold. Unlabeled residues are gray; all others
are colored according to chemical property. The C-terminal tail
of Cdc25A can be seen behind the active site, extending away
from the protein. Graphics rendered with O ( [29]) and VORT
(University of Melbourne).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1998,
93,
617-625)
copyright 1998.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.B.Trunnell,
A.C.Poon,
S.Y.Kim,
and
J.E.Ferrell
(2011).
Ultrasensitivity in the Regulation of Cdc25C by Cdk1.
|
| |
Mol Cell, 41,
263-274.
|
 |
|
|
|
|
 |
G.M.Arantes
(2010).
Flexibility and inhibitor binding in cdc25 phosphatases.
|
| |
Proteins, 78,
3017-3032.
|
 |
|
|
|
|
 |
R.Wysocki,
and
M.J.Tamás
(2010).
How Saccharomyces cerevisiae copes with toxic metals and metalloids.
|
| |
FEMS Microbiol Rev, 34,
925-951.
|
 |
|
|
|
|
 |
A.B.Mamonov,
D.Bhatt,
D.J.Cashman,
Y.Ding,
and
D.M.Zuckerman
(2009).
General library-based Monte Carlo technique enables equilibrium sampling of semi-atomistic protein models.
|
| |
J Phys Chem B, 113,
10891-10904.
|
 |
|
|
|
|
 |
H.K.Yeo,
and
J.Y.Lee
(2009).
Crystal structure of Saccharomyces cerevisiae Ygr203w, a homolog of single-domain rhodanese and Cdc25 phosphatase catalytic domain.
|
| |
Proteins, 76,
520-524.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Hänzelmann,
J.U.Dahl,
J.Kuper,
A.Urban,
U.Müller-Theissen,
S.Leimkühler,
and
H.Schindelin
(2009).
Crystal structure of YnjE from Escherichia coli, a sulfurtransferase with three rhodanese domains.
|
| |
Protein Sci, 18,
2480-2491.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Tsai,
U.Sen,
L.Zhao,
W.B.Greenleaf,
J.Dasgupta,
E.Fiorillo,
V.Orrú,
N.Bottini,
and
X.S.Chen
(2009).
Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation .
|
| |
Biochemistry, 48,
4838-4845.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Dai,
J.Liu,
C.Zheng,
A.Wu,
J.Zeng,
and
G.Qiu
(2009).
Cys92, Cys101, Cys197, and Cys203 are crucial residues for coordinating the iron-sulfur cluster of RhdA from Acidithiobacillus ferrooxidans.
|
| |
Curr Microbiol, 59,
559-564.
|
 |
|
|
|
|
 |
A.Bakan,
J.S.Lazo,
P.Wipf,
K.M.Brummond,
and
I.Bahar
(2008).
Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.
|
| |
Curr Med Chem, 15,
2536-2544.
|
 |
|
|
|
|
 |
B.A.Smith-Donald,
and
B.Roizman
(2008).
The interaction of herpes simplex virus 1 regulatory protein ICP22 with the cdc25C phosphatase is enabled in vitro by viral protein kinases US3 and UL13.
|
| |
J Virol, 82,
4533-4543.
|
 |
|
|
|
|
 |
H.Park,
and
Y.H.Jeon
(2008).
Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure.
|
| |
J Mol Model, 14,
833-841.
|
 |
|
|
|
|
 |
M.S.Rodrigues,
M.M.Reddy,
and
M.Sattler
(2008).
Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications.
|
| |
Antioxid Redox Signal, 10,
1813-1848.
|
 |
|
|
|
|
 |
R.J.Tomko,
and
J.S.Lazo
(2008).
Multimodal control of Cdc25A by nitrosative stress.
|
| |
Cancer Res, 68,
7457-7465.
|
 |
|
|
|
|
 |
J.Phan,
J.E.Tropea,
and
D.S.Waugh
(2007).
Structure-assisted discovery of Variola major H1 phosphatase inhibitors.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
698-704.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Sun,
Y.Chai,
R.Hannigan,
V.K.Bhogaraju,
and
K.Machaca
(2007).
Zinc regulates the ability of Cdc25C to activate MPF/cdk1.
|
| |
J Cell Physiol, 213,
98.
|
 |
|
|
|
|
 |
T.Strahl,
and
J.Thorner
(2007).
Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae.
|
| |
Biochim Biophys Acta, 1771,
353-404.
|
 |
|
|
|
|
 |
X.Tao,
and
L.Tong
(2007).
Crystal structure of the MAP kinase binding domain and the catalytic domain of human MKP5.
|
| |
Protein Sci, 16,
880-886.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Lavecchia,
S.Cosconati,
V.Limongelli,
and
E.Novellino
(2006).
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanism.
|
| |
ChemMedChem, 1,
540-550.
|
 |
|
|
|
|
 |
B.D.Charette,
R.G.Macdonald,
S.Wetzel,
D.B.Berkowitz,
and
H.Waldmann
(2006).
Protein structure similarity clustering: dynamic treatment of PDB structures facilitates clustering.
|
| |
Angew Chem Int Ed Engl, 45,
7766-7770.
|
 |
|
|
|
|
 |
D.Bisacchi,
Y.Zhou,
B.P.Rosen,
R.Mukhopadhyay,
and
D.Bordo
(2006).
Crystallization and preliminary crystallographic characterization of LmACR2, an arsenate/antimonate reductase from Leishmania major.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 62,
976-979.
|
 |
|
|
|
|
 |
G.Roos,
S.Loverix,
E.Brosens,
K.Van Belle,
L.Wyns,
P.Geerlings,
and
J.Messens
(2006).
The activation of electrophile, nucleophile and leaving group during the reaction catalysed by pI258 arsenate reductase.
|
| |
Chembiochem, 7,
981-989.
|
 |
|
|
|
|
 |
M.Hattori,
E.Mizohata,
A.Tatsuguchi,
R.Shibata,
S.Kishishita,
K.Murayama,
T.Terada,
S.Kuramitsu,
M.Shirouzu,
and
S.Yokoyama
(2006).
Crystal structure of the single-domain rhodanese homologue TTHA0613 from Thermus thermophilus HB8.
|
| |
Proteins, 64,
284-287.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.P.Ducruet,
A.Vogt,
P.Wipf,
and
J.S.Lazo
(2005).
Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.
|
| |
Annu Rev Pharmacol Toxicol, 45,
725-750.
|
 |
|
|
|
|
 |
A.Salmeen,
and
D.Barford
(2005).
Functions and mechanisms of redox regulation of cysteine-based phosphatases.
|
| |
Antioxid Redox Signal, 7,
560-577.
|
 |
|
|
|
|
 |
D.Pantoja-Uceda,
B.López-Méndez,
S.Koshiba,
M.Inoue,
T.Kigawa,
T.Terada,
M.Shirouzu,
A.Tanaka,
M.Seki,
K.Shinozaki,
S.Yokoyama,
and
P.Güntert
(2005).
Solution structure of the rhodanese homology domain At4g01050(175-295) from Arabidopsis thaliana.
|
| |
Protein Sci, 14,
224-230.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.J.Dekker,
M.A.Koch,
and
H.Waldmann
(2005).
Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics.
|
| |
Curr Opin Chem Biol, 9,
232-239.
|
 |
|
|
|
|
 |
J.Rudolph
(2005).
Redox regulation of the Cdc25 phosphatases.
|
| |
Antioxid Redox Signal, 7,
761-767.
|
 |
|
|
|
|
 |
K.Hamada,
M.Kato,
T.Shimizu,
K.Ihara,
T.Mizuno,
and
T.Hakoshima
(2005).
Crystal structure of the protein histidine phosphatase SixA in the multistep His-Asp phosphorelay.
|
| |
Genes Cells, 10,
1.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Bialy,
and
H.Waldmann
(2005).
Inhibitors of protein tyrosine phosphatases: next-generation drugs?
|
| |
Angew Chem Int Ed Engl, 44,
3814-3839.
|
 |
|
|
|
|
 |
M.Acosta,
S.Beard,
J.Ponce,
M.Vera,
J.C.Mobarec,
and
C.A.Jerez
(2005).
Identification of putative sulfurtransferase genes in the extremophilic Acidithiobacillus ferrooxidans ATCC 23270 genome: structural and functional characterization of the proteins.
|
| |
OMICS, 9,
13-29.
|
 |
|
|
|
|
 |
M.S.Willis,
J.K.Hogan,
P.Prabhakar,
X.Liu,
K.Tsai,
Y.Wei,
and
T.Fox
(2005).
Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions.
|
| |
Protein Sci, 14,
1818-1826.
|
 |
|
|
|
|
 |
R.Balamurugan,
F.J.Dekker,
and
H.Waldmann
(2005).
Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC).
|
| |
Mol Biosyst, 1,
36-45.
|
 |
|
|
|
|
 |
S.G.Rhee,
K.S.Yang,
S.W.Kang,
H.A.Woo,
and
T.S.Chang
(2005).
Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification.
|
| |
Antioxid Redox Signal, 7,
619-626.
|
 |
|
|
|
|
 |
A.Alonso,
S.Burkhalter,
J.Sasin,
L.Tautz,
J.Bogetz,
H.Huynh,
M.C.Bremer,
L.J.Holsinger,
A.Godzik,
and
T.Mustelin
(2004).
The minimal essential core of a cysteine-based protein-tyrosine phosphatase revealed by a novel 16-kDa VH1-like phosphatase, VHZ.
|
| |
J Biol Chem, 279,
35768-35774.
|
 |
|
|
|
|
 |
D.F.McCain,
L.Wu,
P.Nickel,
M.U.Kassack,
A.Kreimeyer,
A.Gagliardi,
D.C.Collins,
and
Z.Y.Zhang
(2004).
Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases.
|
| |
J Biol Chem, 279,
14713-14725.
|
 |
|
|
|
|
 |
G.Kozlov,
J.Cheng,
E.Ziomek,
D.Banville,
K.Gehring,
and
I.Ekiel
(2004).
Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
|
| |
J Biol Chem, 279,
11882-11889.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Landrieu,
M.da Costa,
L.De Veylder,
F.Dewitte,
K.Vandepoele,
S.Hassan,
J.M.Wieruszeski,
F.Corellou,
J.D.Faure,
M.Van Montagu,
D.Inzé,
and
G.Lippens
(2004).
A small CDC25 dual-specificity tyrosine-phosphatase isoform in Arabidopsis thaliana.
|
| |
Proc Natl Acad Sci U S A, 101,
13380-13385.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Sohn,
K.Kristjánsdóttir,
A.Safi,
B.Parker,
B.Kiburz,
and
J.Rudolph
(2004).
Remote hot spots mediate protein substrate recognition for the Cdc25 phosphatase.
|
| |
Proc Natl Acad Sci U S A, 101,
16437-16441.
|
 |
|
|
|
|
 |
K.Kristjánsdóttir,
and
J.Rudolph
(2004).
Cdc25 phosphatases and cancer.
|
| |
Chem Biol, 11,
1043-1051.
|
 |
|
|
|
|
 |
M.A.Koch,
L.O.Wittenberg,
S.Basu,
D.A.Jeyaraj,
E.Gourzoulidou,
K.Reinecke,
A.Odermatt,
and
H.Waldmann
(2004).
Compound library development guided by protein structure similarity clustering and natural product structure.
|
| |
Proc Natl Acad Sci U S A, 101,
16721-16726.
|
 |
|
|
|
|
 |
M.D.Wolfe,
F.Ahmed,
G.M.Lacourciere,
C.T.Lauhon,
T.C.Stadtman,
and
T.J.Larson
(2004).
Functional diversity of the rhodanese homology domain: the Escherichia coli ybbB gene encodes a selenophosphate-dependent tRNA 2-selenouridine synthase.
|
| |
J Biol Chem, 279,
1801-1809.
|
 |
|
|
|
|
 |
M.S.Alphey,
R.A.Williams,
J.C.Mottram,
G.H.Coombs,
and
W.N.Hunter
(2003).
The crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase. A three-domain architecture with a serine protease-like triad at the active site.
|
| |
J Biol Chem, 278,
48219-48227.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.S.Chen,
C.E.Ryan,
and
H.Piwnica-Worms
(2003).
Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding.
|
| |
Mol Cell Biol, 23,
7488-7497.
|
 |
|
|
|
|
 |
N.Lah,
J.Lah,
I.Zegers,
L.Wyns,
and
J.Messens
(2003).
Specific potassium binding stabilizes pI258 arsenate reductase from Staphylococcus aureus.
|
| |
J Biol Chem, 278,
24673-24679.
|
 |
|
|
|
|
 |
P.Turowski,
C.Franckhauser,
M.C.Morris,
P.Vaglio,
A.Fernandez,
and
N.J.Lamb
(2003).
Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells.
|
| |
Mol Biol Cell, 14,
2984-2998.
|
 |
|
|
|
|
 |
R.Li,
J.D.Haile,
and
P.J.Kennelly
(2003).
An arsenate reductase from Synechocystis sp. strain PCC 6803 exhibits a novel combination of catalytic characteristics.
|
| |
J Bacteriol, 185,
6780-6789.
|
 |
|
|
|
|
 |
R.Mukhopadhyay,
Y.Zhou,
and
B.P.Rosen
(2003).
Directed evolution of a yeast arsenate reductase into a protein-tyrosine phosphatase.
|
| |
J Biol Chem, 278,
24476-24480.
|
 |
|
|
|
|
 |
T.van der Wijk,
C.Blanchetot,
J.Overvoorde,
and
J.den Hertog
(2003).
Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers.
|
| |
J Biol Chem, 278,
13968-13974.
|
 |
|
|
|
|
 |
B.I.Carr,
Z.Wang,
and
S.Kar
(2002).
K vitamins, PTP antagonism, and cell growth arrest.
|
| |
J Cell Physiol, 193,
263-274.
|
 |
|
|
|
|
 |
C.Blanchetot,
L.G.Tertoolen,
and
J.den Hertog
(2002).
Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress.
|
| |
EMBO J, 21,
493-503.
|
 |
|
|
|
|
 |
D.Bordo,
and
P.Bork
(2002).
The rhodanese/Cdc25 phosphatase superfamily. Sequence-structure-function relations.
|
| |
EMBO Rep, 3,
741-746.
|
 |
|
|
|
|
 |
D.F.McCain,
I.E.Catrina,
A.C.Hengge,
and
Z.Y.Zhang
(2002).
The catalytic mechanism of Cdc25A phosphatase.
|
| |
J Biol Chem, 277,
11190-11200.
|
 |
|
|
|
|
 |
L.N.Johnson,
E.De Moliner,
N.R.Brown,
H.Song,
D.Barford,
J.A.Endicott,
and
M.E.Noble
(2002).
Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.
|
| |
Pharmacol Ther, 93,
113-124.
|
 |
|
|
|
|
 |
M.A.Lyon,
A.P.Ducruet,
P.Wipf,
and
J.S.Lazo
(2002).
Dual-specificity phosphatases as targets for antineoplastic agents.
|
| |
Nat Rev Drug Discov, 1,
961-976.
|
 |
|
|
|
|
 |
P.A.Savitsky,
and
T.Finkel
(2002).
Redox regulation of Cdc25C.
|
| |
J Biol Chem, 277,
20535-20540.
|
 |
|
|
|
|
 |
P.J.Kennelly
(2002).
Protein kinases and protein phosphatases in prokaryotes: a genomic perspective.
|
| |
FEMS Microbiol Lett, 206,
1-8.
|
 |
|
|
|
|
 |
R.Mukhopadhyay,
B.P.Rosen,
L.T.Phung,
and
S.Silver
(2002).
Microbial arsenic: from geocycles to genes and enzymes.
|
| |
FEMS Microbiol Rev, 26,
311-325.
|
 |
|
|
|
|
 |
R.Mukhopadhyay,
and
B.P.Rosen
(2002).
Arsenate reductases in prokaryotes and eukaryotes.
|
| |
Environ Health Perspect, 110,
745-748.
|
 |
|
|
|
|
 |
T.S.Chang,
W.Jeong,
S.Y.Choi,
S.Yu,
S.W.Kang,
and
S.G.Rhee
(2002).
Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation.
|
| |
J Biol Chem, 277,
25370-25376.
|
 |
|
|
|
|
 |
A.Changela,
C.K.Ho,
A.Martins,
S.Shuman,
and
A.Mondragón
(2001).
Structure and mechanism of the RNA triphosphatase component of mammalian mRNA capping enzyme.
|
| |
EMBO J, 20,
2575-2586.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Spallarossa,
J.L.Donahue,
T.J.Larson,
M.Bolognesi,
and
D.Bordo
(2001).
Escherichia coli GlpE is a prototype sulfurtransferase for the single-domain rhodanese homology superfamily.
|
| |
Structure, 9,
1117-1125.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Bordo,
F.Forlani,
A.Spallarossa,
R.Colnaghi,
A.Carpen,
M.Bolognesi,
and
S.Pagani
(2001).
A persulfurated cysteine promotes active site reactivity in Azotobacter vinelandii Rhodanese.
|
| |
Biol Chem, 382,
1245-1252.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Song,
N.Hanlon,
N.R.Brown,
M.E.Noble,
L.N.Johnson,
and
D.Barford
(2001).
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
|
| |
Mol Cell, 7,
615-626.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Bennett,
Z.Guan,
M.Laurberg,
and
X.D.Su
(2001).
Bacillus subtilis arsenate reductase is structurally and functionally similar to low molecular weight protein tyrosine phosphatases.
|
| |
Proc Natl Acad Sci U S A, 98,
13577-13582.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.K.Tonks,
and
B.G.Neel
(2001).
Combinatorial control of the specificity of protein tyrosine phosphatases.
|
| |
Curr Opin Cell Biol, 13,
182-195.
|
 |
|
|
|
|
 |
P.Martin,
S.DeMel,
J.Shi,
T.Gladysheva,
D.L.Gatti,
B.P.Rosen,
and
B.F.Edwards
(2001).
Insights into the structure, solvation, and mechanism of ArsC arsenate reductase, a novel arsenic detoxification enzyme.
|
| |
Structure, 9,
1071-1081.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.T.Stukenberg,
and
M.W.Kirschner
(2001).
Pin1 acts catalytically to promote a conformational change in Cdc25.
|
| |
Mol Cell, 7,
1071-1083.
|
 |
|
|
|
|
 |
R.R.Copley,
R.B.Russell,
and
C.P.Ponting
(2001).
Sialidase-like Asp-boxes: sequence-similar structures within different protein folds.
|
| |
Protein Sci, 10,
285-292.
|
 |
|
|
|
|
 |
X.Zou,
T.Tsutsui,
D.Ray,
J.F.Blomquist,
H.Ichijo,
D.S.Ucker,
and
H.Kiyokawa
(2001).
The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1.
|
| |
Mol Cell Biol, 21,
4818-4828.
|
 |
|
|
|
|
 |
Z.Q.Ma,
Z.Liu,
E.S.Ngan,
and
S.Y.Tsai
(2001).
Cdc25B functions as a novel coactivator for the steroid receptors.
|
| |
Mol Cell Biol, 21,
8056-8067.
|
 |
|
|
|
|
 |
C.C.Fjeld,
A.E.Rice,
Y.Kim,
K.R.Gee,
and
J.M.Denu
(2000).
Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase.
|
| |
J Biol Chem, 275,
6749-6757.
|
 |
|
|
|
|
 |
D.M.Taverna,
and
R.A.Goldstein
(2000).
The distribution of structures in evolving protein populations.
|
| |
Biopolymers, 53,
1-8.
|
 |
|
|
|
|
 |
H.Peng,
W.Xie,
D.I.Kim,
L.H.Zalkow,
G.Powis,
D.M.Otterness,
and
R.T.Abraham
(2000).
Steroidal derived acids as inhibitors of human Cdc25A protein phosphatase.
|
| |
Bioorg Med Chem, 8,
299-306.
|
 |
|
|
|
|
 |
J.Moon,
Y.S.Kim,
J.Y.Lee,
S.J.Cho,
H.K.Song,
J.H.Cho,
B.M.Kim,
K.K.Kim,
and
S.W.Suh
(2000).
Crystallization and preliminary X-ray diffraction analysis of Saccharomyces cerevisiae Ygr203p, a homologue of Acr2 arsenate reductase.
|
| |
Acta Crystallogr D Biol Crystallogr, 56,
778-780.
|
 |
|
|
|
|
 |
P.Herrlich,
and
F.D.Böhmer
(2000).
Redox regulation of signal transduction in mammalian cells.
|
| |
Biochem Pharmacol, 59,
35-41.
|
 |
|
|
|
|
 |
P.M.Palenchar,
C.J.Buck,
H.Cheng,
T.J.Larson,
and
E.G.Mueller
(2000).
Evidence that ThiI, an enzyme shared between thiamin and 4-thiouridine biosynthesis, may be a sulfurtransferase that proceeds through a persulfide intermediate.
|
| |
J Biol Chem, 275,
8283-8286.
|
 |
|
|
|
|
 |
S.Wang,
L.Tabernero,
M.Zhang,
E.Harms,
R.L.Van Etten,
and
C.V.Stauffacher
(2000).
Crystal structures of a low-molecular weight protein tyrosine phosphatase from Saccharomyces cerevisiae and its complex with the substrate p-nitrophenyl phosphate.
|
| |
Biochemistry, 39,
1903-1914.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Noelle,
N.Tennagels,
and
H.W.Klein
(2000).
A single substitution of the insulin receptor kinase inhibits serine autophosphorylation in vitro: evidence for an interaction between the C-terminus and the activation loop.
|
| |
Biochemistry, 39,
7170-7177.
|
 |
|
|
|
|
 |
W.Chen,
M.Wilborn,
and
J.Rudolph
(2000).
Dual-specific Cdc25B phosphatase: in search of the catalytic acid.
|
| |
Biochemistry, 39,
10781-10789.
|
 |
|
|
|
|
 |
W.K.Ray,
G.Zeng,
M.B.Potters,
A.M.Mansuri,
and
T.J.Larson
(2000).
Characterization of a 12-kilodalton rhodanese encoded by glpE of Escherichia coli and its interaction with thioredoxin.
|
| |
J Bacteriol, 182,
2277-2284.
|
 |
|
|
|
|
 |
B.Kobe,
T.Gleichmann,
J.Horne,
I.G.Jennings,
P.D.Scotney,
and
T.Teh
(1999).
Turn up the HEAT.
|
| |
Structure, 7,
R91-R97.
|
 |
|
|
|
|
 |
B.P.Rosen
(1999).
Families of arsenic transporters.
|
| |
Trends Microbiol, 7,
207-212.
|
 |
|
|
|
|
 |
B.Zhou,
and
Z.Y.Zhang
(1999).
Mechanism of mitogen-activated protein kinase phosphatase-3 activation by ERK2.
|
| |
J Biol Chem, 274,
35526-35534.
|
 |
|
|
|
|
 |
I.Blomberg,
and
I.Hoffmann
(1999).
Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases.
|
| |
Mol Cell Biol, 19,
6183-6194.
|
 |
|
|
|
|
 |
J.A.Endicott,
M.E.Noble,
and
J.A.Tucker
(1999).
Cyclin-dependent kinases: inhibition and substrate recognition.
|
| |
Curr Opin Struct Biol, 9,
738-744.
|
 |
|
|
|
|
 |
M.Taing,
Y.F.Keng,
K.Shen,
L.Wu,
D.S.Lawrence,
and
Z.Y.Zhang
(1999).
Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B.
|
| |
Biochemistry, 38,
3793-3803.
|
 |
|
|
|
|
 |
S.Gross,
A.Knebel,
T.Tenev,
A.Neininger,
M.Gaestel,
P.Herrlich,
and
F.D.Böhmer
(1999).
Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction.
|
| |
J Biol Chem, 274,
26378-26386.
|
 |
|
|
|
|
 |
X.L.Zhan,
and
K.L.Guan
(1999).
A specific protein-protein interaction accounts for the in vivo substrate selectivity of Ptp3 towards the Fus3 MAP kinase.
|
| |
Genes Dev, 13,
2811-2827.
|
 |
|
|
|
|
 |
J.M.Denu,
and
J.E.Dixon
(1998).
Protein tyrosine phosphatases: mechanisms of catalysis and regulation.
|
| |
Curr Opin Chem Biol, 2,
633-641.
|
 |
|
|
|
|
 |
R.Mukhopadhyay,
and
B.P.Rosen
(1998).
Saccharomyces cerevisiae ACR2 gene encodes an arsenate reductase.
|
| |
FEMS Microbiol Lett, 168,
127-136.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|